Cargando…
Chimeric Antigen Receptor Based Therapy as a Potential Approach in Autoimmune Diseases: How Close Are We to the Treatment?
Despite significant breakthroughs in understanding of immunological and physiological features of autoimmune diseases, there is currently no specific therapeutic option with prolonged remission. Cell-based therapy using engineered-T cells has attracted tremendous attention as a practical treatment f...
Autores principales: | Sadeqi Nezhad, Muhammad, Seifalian, Alexander, Bagheri, Nader, Yaghoubi, Sajad, Karimi, Mohammad Hossein, Adbollahpour-Alitappeh, Meghdad |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7727445/ https://www.ncbi.nlm.nih.gov/pubmed/33324420 http://dx.doi.org/10.3389/fimmu.2020.603237 |
Ejemplares similares
-
Investigating the sequential patterns of methamphetamine use initiation in Iran
por: Sarani, Ebrahim Moghimi, et al.
Publicado: (2020) -
Mimicking Antigen-Driven Asthma in Rodent Models—How Close Can We Get?
por: Alessandrini, Francesca, et al.
Publicado: (2020) -
B cell depletion therapies in autoimmune diseases: Monoclonal antibodies or chimeric antigen receptor-based therapy?
por: Zhang, Zheng, et al.
Publicado: (2023) -
The Chimeric Antigen Receptor Detection Toolkit
por: Hu, Yifei, et al.
Publicado: (2020) -
Cutting-Edge Technologies for Inflamed Joints on Chip: How Close Are We?
por: Kahraman, Emine, et al.
Publicado: (2022)